Personal Products Corp. v. Allen Laboratories, Inc.

141 F.2d 702, 31 C.C.P.A. 889, 61 U.S.P.Q. (BNA) 187, 1944 CCPA LEXIS 27
CourtCourt of Customs and Patent Appeals
DecidedFebruary 7, 1944
DocketNo. 4799
StatusPublished
Cited by3 cases

This text of 141 F.2d 702 (Personal Products Corp. v. Allen Laboratories, Inc.) is published on Counsel Stack Legal Research, covering Court of Customs and Patent Appeals primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Personal Products Corp. v. Allen Laboratories, Inc., 141 F.2d 702, 31 C.C.P.A. 889, 61 U.S.P.Q. (BNA) 187, 1944 CCPA LEXIS 27 (ccpa 1944).

Opinions

Hatfield, Judge,

delivered the opinion of the court:

This is an appeal in a trade-mark opposition proceeding from the decision of the Commissioner of Patents affirming the decision of the Examiner of Interferences, sustaining appellee’s notice of opposition and holding that appellant was not entitled to the registration of its trade-mark “MEDS” for use on “tampons.”

[890]*890It appears from the record that appellant’s trade-mark “MEDS” is used on an unmedicated internal catamenial device, comprising telescopically arranged paper tubes and a cotton tampon having a withdrawal string attached thereto and extending outwardly through the inner tube; that appellant sells its goods at retail to the general public through drug stores, chain stores, and department stores throughout the United States at twenty cents per package of ten tampons; and that it has expended approximately $375,000 in advertising its product and its trade-mark in newspapers and magazines throughout the United States.

In its application for registration, filed June 25, 1940, appellant alleged that it had used its trade-mark on its goods since June 21, 1939.

Appellee is the owner of trade-mark registration No. 348,970, issued August 17, 1937, on an application filed February 24, 1937, for the trade-mark “MED-I-PAX” for use on “MEDICATED VAGINAL SUPPOSITORIES,” although it appears from the record that it advertises and sells its goods as “vaginal tampon suppositories” under the trade-mark “Medipax.”

The goods of the parties are of substantially the same construction, except that in appellee’s device a medicated suppository, molded to facilitate easy insertion, is attached to the upper end of the cotton tampon. Appellee’s device is “used for medical treatment” and not as a “catamenial device.” It is used in the treatment of “gynecologic conditions,” and is, therefore, for the prevention, cure, or alleviation of disease. The medication consists of either metaphen or merthiolate. In appellee’s device the cotton tampon to which the medicated suppository is attached is designed to hold the medicament in the area of infection or inflammation and to absorb exudates.

It further appears from the record that appellee’s goods are “ethical” products; that they are sold at $1.00 per package of six by druggists on physicians’ prescriptions, although they may be purchased without such prescriptions; that appellee has expended approximately $15,000 in advertising its goods and its trade-mark; that they are advertised in medical journals, by contact with physicians, by exhibits at medical conventions, and, as stated by appellee’s witness, E. A. Griswold, vice president of the opposer company, through a physician in the employ of the appellee company “whose only duty is to interest hospitals and clinics as well as members of the medical profession in the use of Medipax Brand Vaginal Tampon-Suppositories. His duties also include the organization of clinical research at such institutions.”

Appellee’s goods are hot advertised for sale to the general public through magazines and newspapers as are appellant’s catamenial tampons.

[891]*891The witness Griswold testified on direct examination that the ap-pellee company was incorporated on December 24, 1938; that he had been vice president of the company since January 27, 1939; and that he had been engaged in the manufacture of drug and pharmaceutical products for more than ten years. We quote from the testimony of the witness as follows:

Q. 46. What does the word “Med” mean/to you?
sfc # * * $ * *
A. The word “Med” appears in the Funk & Wagnall’s Standard Dictionary, in Webster’s New International Dictionary, and in the New Century Dictionary as an abbreviation for medical or medicine.
Q. 49. Is that what the word means to you?
A. I think that is correct.

The tribunals of the Patent Office concurred in holding that the-goods of the parties possessed the same descriptive properties; that the marks were confusingly similar; and that appellant was not entitled to the registration of .its mark.

In his decision holding the marks to be confusingly similar, the commissioner stated, among other things, that, although the goods of the respective parties are not competitive, they—

are very closely associated in use, and may reasonably be assumed to be produced by the same manufacturer. I doubt that one would be mistaken for the other, but if sold under similar trade-marks I am convinced that there is at least some likelihood of confusion as to origin. In reaching this conclusion I have not overlooked existing differences in price and in methods of sale. Both are subject to change. Nor is it material that there is no evidence of actual confusion.

Although it is stated in appellant’s reasons of appeal that the goods of the parties do not possess the same descriptive properties, that issue is not discussed in appellant’s brief. Accordingly, it is unnecessary for us to discuss it here. [2] It is sufficient to say that *we are in agreement with the views expressed by the tribunals of the Patent Office that the goods of the parties possess the same descriptive properties.

It is contended, here by counsel for appellant that, considering the differences in the trade-marks of the parties and the goods to which they are applied, the marks are not confusingly similar; that appellant’s trade-mark “MEDS” is a coined, arbitrary mark, and, as applied to appellant’s goods, has no descriptive significance; that apart from the syllable “MED” in appellee’s mark, there is no similarity between the marks of the parties; that as the syllable “MED” in appellee’s mark is an abbreviation of the terms ‘medical” or “medicine,” as used in appellee’s mark, it is descriptive of the character and quality of appellee’s goods and therefore is not the dominant feature of appel-lee’s trade-mark; that appellee is not entitled to its exclusive use; and that appellant’s trade-mark “MEDS” was “adopted as a contraction [892]*892of appellant’s well-known trade-mark ‘MODESS,’ extensively used as applied to catamenial napkins, a competitive product then and now-sold on an extensive scale.” (It- may be said at this point that, although it appears from the record that appellant manufactures and sells catamenial napkins under the term “MODESS,” it does not appear that the term “MEDS” was adopted as a contraction of the term “MODESS.”)

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Dietene Co. v. Dietrim Co.
121 F. Supp. 785 (D. Nebraska, 1954)
Charles of the Ritz, Inc. v. Elizabeth Arden Sales Corp.
161 F.2d 234 (Customs and Patent Appeals, 1947)

Cite This Page — Counsel Stack

Bluebook (online)
141 F.2d 702, 31 C.C.P.A. 889, 61 U.S.P.Q. (BNA) 187, 1944 CCPA LEXIS 27, Counsel Stack Legal Research, https://law.counselstack.com/opinion/personal-products-corp-v-allen-laboratories-inc-ccpa-1944.